Francois Lamontagne Selected Research

Francois Lamontagne Research Topics

Disease

30	Critical Illness (Critically Ill) 11/2023 - 11/2009
20	COVID-19 01/2024 - 01/2020
7	Infections 01/2024 - 07/2013
7	Sepsis (Septicemia) 12/2023 - 12/2008
7	Hypotension (Low Blood Pressure) 01/2023 - 10/2011
6	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 03/2014
6	Shock 10/2020 - 06/2008
5	Septic Shock (Toxic Shock Syndrome) 11/2023 - 06/2008
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024 - 03/2010
4	Human Influenza (Influenza) 01/2024 - 11/2009
3	Bacteremia 02/2018 - 04/2015
3	Coinfection 02/2018 - 07/2013
2	Hypertension (High Blood Pressure) 07/2021 - 01/2017
2	Body Weight (Weight, Body) 01/2021 - 12/2017
2	Cross Infection (Nosocomial Infection) 01/2018 - 09/2016
2	Hypoxia (Hypoxemia) 12/2017 - 11/2009
2	Acidosis 07/2017 - 07/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2015 - 02/2015
2	Venous Thromboembolism 09/2015 - 02/2015
2	Pulmonary Embolism 09/2015 - 02/2015
2	Thrombosis (Thrombus) 06/2014 - 05/2014
2	Thrombocytopenia (Thrombopenia) 06/2014 - 10/2013
1	Pneumonia (Pneumonitis) 01/2024
1	Bacterial Pneumonia 01/2024
1	Lung Diseases (Lung Disease) 12/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2022
1	Diabetes Mellitus 07/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2021
1	Chronic Renal Insufficiency 07/2021
1	Hemorrhage 05/2021

Drug/Important Bio-Agent (IBA)

7	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 08/2018
6	Heparin (Liquaemin)FDA LinkGeneric 08/2021 - 05/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2013
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2023 - 01/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2023 - 07/2021
3	Angiotensin Receptor AntagonistsIBA 11/2023 - 07/2021
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2023 - 07/2021
3	Antiviral Agents (Antivirals)IBA 08/2021 - 01/2020
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2015 - 10/2013
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2022
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2023 - 11/2023
2	Neuromuscular Blocking AgentsIBA 11/2023 - 12/2017
2	sarilumabIBA 01/2022 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2020 - 06/2008
2	Oxygen (Dioxygen)IBA 09/2020 - 07/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020 - 12/2019
2	boldenone undecylenate (Equipoise)IBA 02/2018 - 01/2018
2	ChloridesIBA 01/2018 - 07/2017
2	LactoferrinIBA 01/2018 - 09/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2017 - 10/2011
2	ElectrolytesIBA 07/2016 - 10/2014
1	Tryptophan (L-Tryptophan)FDA Link 01/2024
1	Histidine (L-Histidine)FDA Link 01/2024
1	Arginine (L-Arginine)FDA Link 01/2024
1	Lysine (L-Lysine)FDA Link 01/2024
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2024
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2024
1	Pyruvic Acid (Pyruvate)IBA 01/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Taurine FDA Link 01/2024
1	Glutamine (L-Glutamine)FDA Link 01/2024
1	Proline (L-Proline)FDA Link 01/2024
1	hypotaurineIBA 01/2024
1	Tyrosine (L-Tyrosine)FDA Link 01/2024
1	Blood Proteins (Serum Proteins)IBA 12/2023
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	remdesivirIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Lopinavir FDA Link 08/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2021
1	Ritonavir (Norvir)FDA Link 08/2021
1	AerosolsIBA 01/2021
1	casirivimab and imdevimab drug combinationIBA 01/2021
1	bamlanivimabIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	regdanvimabIBA 01/2021
1	XAV-19IBA 01/2021
1	sotrovimabIBA 01/2021
1	AntibodiesIBA 01/2021
1	bamlanivimab and etesevimab drug combinationIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021

Therapy/Procedure

20	Therapeutics 11/2023 - 11/2009
8	Critical Care (Surgical Intensive Care) 01/2024 - 07/2013
8	Artificial Respiration (Mechanical Ventilation) 11/2023 - 11/2009
7	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023 - 10/2013
4	Length of Stay 11/2023 - 09/2016
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2023 - 03/2010
3	Duration of Therapy 02/2018 - 04/2015
3	Resuscitation 01/2018 - 12/2017
2	Enteral Nutrition (Feeding, Tube) 01/2020 - 01/2018
1	Extracorporeal Membrane Oxygenation 11/2023
1	Mechanical Ventilators (Ventilator) 11/2023
1	Renal Dialysis (Hemodialysis) 05/2021
1	Continuous Renal Replacement Therapy 05/2021
1	Peritoneal Dialysis 05/2021
1	Patient Isolation 01/2021
1	Plasma Exchange 01/2021
1	Personal Protective Equipment 01/2021